NA
Nath Bio-Genes (India) Limited
NATHBIOGEN.NS · NSE
₹152.00 -0.01% (-₹0.01)
1M -2.66%
Market Cap ₹2.89B
P/E Ratio 7.47x
Div. Yield -
ROE 5.69%
Bulios Fair Price
₹219.17
44.2% upside
Current Price
₹152
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NATHBIOGEN.NS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap EV/EBITDA 4.71x
P/S 0.59x
P/B 0.42x
Growth
77 /100
Growing Book val. growth 5.94%
Rev. growth 9.44%
FCF growth N/A
Profitability
53 /100
Moderate Net margin 7.90%
Op. margin 9.25%
FCF margin 22.41%
Quality
42 /100
Average ROE 5.69%
ROA N/A
Asset turnover N/A
Debt
89 /100
Low Int. coverage 3.36x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
60 /100
Moderate Rev. volatility 32.85%
EPS volatility 85.06%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NATHBIOGEN.NS
Online
Sector
Basic Materials
Industry
Agricultural Inputs
CEO
Satish Kagliwal
Employees
423
Headquarters
Mumbai
Upcoming events
11 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date